Assessment of cardiac iron deposition in sickle cell disease using 3.0 Tesla cardiovascular magnetic resonance

Hemoglobin
El-Sayed H IbrahimRichard D White

Abstract

Many patients with sickle cell disease receive blood transfusions as a life-saving treatment. However, excess transfusions may lead to increased body iron burden. Specifically, heart failure due to cardiac iron overload is the leading cause of death in these patients. The purpose of this study was to investigate the potential role of high-field 3.0-Tesla (T) cardiovascular magnetic resonance (CMR) for assessment of cardiac iron content by measuring the transverse relaxivity rate R2*. The R2* was measured in calibrated phantoms with different iron concentrations at 3.0T and 1.5T using optimized pulse sequences. Myocardial R2* was measured at 3.0T in a group of sickle cell disease patients with different disease stages, and the results were compared to the serum ferritin levels and hepatic R2*. The phantom R2* measurements at 3.0T were double those at 1.5T, and the measurements of both systems showed linear relationships with iron concentration. The 3.0T R2* was more sensitive than 1.5T in detecting low iron concentration. In patients, myocardial R2* had weak and good correlations with hepatic R2* and serum ferritin levels, respectively. Bland-Altman analysis showed low inter- and intra-observer variabilities. In conclusion, meas...Continue Reading

References

Jul 1, 1989·The American Journal of Medicine·D L JohnstonR Rokey
Jan 1, 1983·Critical Reviews in Clinical Laboratory Sciences·G D McLarenR W Kellermeyer
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Apr 1, 1994·The British Journal of Radiology·S BondestamP Ruutu
Sep 11, 1997·The New England Journal of Medicine·H F Bunn
Aug 26, 2004·British Journal of Haematology·Ersi VoskaridouDimitris Loukopoulos
Dec 6, 2005·Journal of Magnetic Resonance Imaging : JMRI·Nilesh R GhugreJohn C Wood
Dec 13, 2005·Annals of the New York Academy of Sciences·Dudley J Pennell
Dec 24, 2005·Journal of Magnetic Resonance Imaging : JMRI·Efthymia AlexopoulouNikolaos L Kelekis
Feb 28, 2007·Journal of Magnetic Resonance Imaging : JMRI·Pippa StoreyCynthia K Rigsby
Apr 7, 2007·Current Opinion in Hematology·John C Wood
Aug 31, 2007·Journal of Magnetic Resonance Imaging : JMRI·Mark A WestwoodDudley J Pennell
Oct 31, 2007·American Journal of Hematology·John B Porter
Feb 27, 2009·Current Opinion in Pediatrics·Shannon Wahl, Keith C Quirolo
Mar 7, 2009·Blood·Jane S HankinsClaudia M Hillenbrand
Apr 27, 2011·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Stéphanie SeldrumBernhard L Gerber

❮ Previous
Next ❯

Citations

Feb 14, 2016·International Journal of Hematology·Gabriel C CamargoIlan Gottlieb
Jun 1, 2016·Journal of Magnetic Resonance Imaging : JMRI·El-Sayed H IbrahimAhmed K Eldaly
Jul 9, 2016·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Mohammed H AlamDudley J Pennell
Dec 27, 2016·Transfusion·Hellen OduorCourtney D Fitzhugh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.